Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07140848 · ClinicalTrials.gov registry record · NA
CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes
A NA study, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- NA
- Development phase
- 214
- Enrollment target
NCT07140848 is a NA study that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 214 participants.
The verdict
NCT07140848, a NA study, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
Study Summary
Prediabetes affects over one-third of adults in the United States, placing them at a higher risk for developing type 2 diabetes and heart disease, which can lead to serious health complications and increased medical costs. Although a program called the Diabetes Prevention Program (DPP) has been shown to lower the risk of diabetes through healthy lifestyle changes, many people find it difficult to stick with these changes over the long term. This study seeks to find out if combining DPP coaching with continuous glucose monitoring (CGM) technology can help people stay on track with their health goals.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL CGM-DPP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2026-04-13 |
| Est. Completion | 2028-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07140848
The ClinicalTrials.gov registry entry for NCT07140848 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT07140848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07140848 about?
NCT07140848 is a clinical study titled "CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes". Prediabetes affects over one-third of adults in the United States, placing them at a higher risk for developing type 2 diabetes and heart disease, which can lead to serious health complications and increased medical costs. Although a program called the Diabetes Prevention Program (DPP) has been show...
What is the current status of trial NCT07140848?
This trial is currently recruiting. It is a NA study. The enrollment target is 214 participants. The study started on 2026-04-13. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07140848?
The interventions under investigation include: Control (BEHAVIORAL), CGM-DPP (BEHAVIORAL).
Who is sponsoring clinical trial NCT07140848?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.